NTLA
Intellia TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
NTLA vs peer average
90/100
NTLA vs. peer average (A vs. C)
Grade spread
B 3 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Broad commercial-biotech benchmark only; its diversified marketed portfolio makes direct valuation comparison with development-stage Intellia weak.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NTLA
Intellia Therapeutics
AMGN
Amgen
Grade
A
D
Momentum
53
93
Value
41
61
Sentiment
84
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
NTLA / AMGN
Grade Position
Above peers
NTLA vs. peer average (A vs. C)
90/100
Momentum
53
AMGNValue
41
AMGNSentiment
84
NTLARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NTLA
AMGN is the first peer returned for this comparison set.